References November 2023 - issue 184


  1. Belgers et al (2023). Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis. Cannabis Cannabinoid Res. 8(1):41-55
  2. Talwar et al (2023). Clinical efficacy and safety of cannabidiol for paediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 114238
  3. Häuser et al (2023). Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database Syst Rev. (6):CD014915
  4. Spanagel and Bilbao (2021). Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite. Neuropharmacology. 196:108680
  5. Blessing et al (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 12(4):825-36
  6. Fazlollahi et al (2023). Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis. JAMA Netw Open. 6(4):e239126
  7. Lo et al (2023). Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 293(6):724-752
  8. Bonn-Miller et al (2017). Labelling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 318(17):1708-1709


  1. Salomon J, De Truchis P and Melchior J (2002). Nutrition and HIV infection. British Journal of Nutrition, 87(S1), S111-S119. doi:10.1079/BJN2001464
  2. HIV in the UK | aidsmap.
  3. Life expectancy for people living with HIV | aidsmap.
  4. Li R, Duffee D, Gbadamosi-Akindele MF. CD4 Count. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2022. PMID: 29262137
  5. CD4 cell counts | aidsmap.
  6. Elfstrand L and Florén H (2010). Management of chronic diarrhea in HIV-infected patients: Current treatment options, challenges and future directions. HIV/AIDS (Auckland, NZ), 2,219-224.
  7. Hosain Pour A, Salari S, Ghasemi Nejad Almani P. Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran. Curr Med Mycol. 2018 Dec;4(4):1-6. doi: 10.18502/cmm.4.4.379. PMID: 30815610; PMCID: PMC6386505
  8. S FA, Madhu M, Udaya Kumar V, Dhingra S, Kumar N, Singh S, Ravichandiran V, Murti K. Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an insight. Curr Pharmacol Rep. 2022;8(5):350-364. doi: 10.1007/s40495-022-00301-z. Epub 2022 Aug 6. PMID: 35966952; PMCID: PMC9362559
  9. Peltenburg NC, Schoeman JC, Hou J, Mora F, Harms AC, Lowe SH, Bierau J, Bakker JA., Verbon A, Hankemeier T, Boonstra A (2018). Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy. Scientific Reports, 8(1), 1-11.
  10. Kumar S and Samaras K (2018). The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality. Frontiers in Endocrinology, 9, 409993.
  11. Masenga SK, Elijovich F, Koethe JR et al. Hypertension and Metabolic Syndrome in Persons with HIV. Curr Hypertens Rep 22, 78 (2020).
  12. Whiteley LB, Olsen EM, Haubrick KK et al. A Review of Interventions to Enhance HIV Medication Adherence. Curr HIV/AIDS Rep 18, 443-457 (2021).
  13. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, Tsai AC. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640. doi: 10.7448/IAS.16.3.18640. PMID: 24242258; PMCID: PMC3833107
  14. Sweeney SM and Vanable PA (2016). The Association of HIV-Related Stigma to HIV Medication Adherence: A Systematic Review and Synthesis of the Literature. AIDS and Behavior, 20(1), 29-50.
  15. Ockenga J, Grimble R, Jonkers-Schuitema C, Macallan D, Melchior JC, Sauerwein HP, Schwenk A; DGEM (German Society for Nutritional Medicine); Süttmann U; ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases. Clin Nutr. 2006 Apr;25(2):319-29. doi: 10.1016/j.clnu.2006.01.016. Epub 2006 May 15. PMID: 16698147.
  16. Food and water safety for people living with HIV | aidsmap.


  1. Gibson R. Chrono nutrition – a new dietary dimension. 2020. Accessed 1st July 2023.
  2. Flanagan A, Bechtold DA, Pot GK et al. Chrono-nutrition: From molecular and neuronal mechanisms to human epidemiology and timed feeding patterns. J Neurochem. 2021 Apr;157(1):53-72. doi: 10.1111/jnc.15246. Epub 2020 Dec 10. PMID: 33222161.
  3. Brown T. Melanopic illuminance defines the magnitude of human circadian light responses under a wide range of conditions. Journal of Pineal Research 2020;69:e12655.
  4. Charlot A, Hutt F, Sabatier E et al. Beneficial Effects of Early Time-Restricted Feeding on Metabolic Diseases: Importance of Aligning Food Habits with the Circadian Clock. Nutrients 2021 Apr 22;13(5):1405. doi: 10.3390/nu13051405. PMID: 33921979; PMCID: PMC8143522.
  5. Espelund U, Hansen TK, Højlund K et al. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J Clin Endocrinol Metab 2005 Feb;90(2):741-6. doi: 10.1210/jc.2004-0604. Epub 2004 Nov 2. PMID: 15522942.
  6. Gill S, Panda S. A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits. Cell Metab 2015 Nov 3;22(5):789-98. doi: 10.1016/j.cmet.2015.09.005. Epub 2015 Sep 24. PMID: 26411343; PMCID: PMC4635036.
  7. An R, Shi Y, Clarke C et al. Night-time eating and body weight status among US adults, 2007-2016. J Hum Nutr Diet 2019 Dec;32(6):754-764. doi: 10.1111/jhn.12671. Epub 2019 May 29. PMID: 31144413.
  8. Yoshida J, Eguchi E, Nagaoka K et al. Association of night eating habits with metabolic syndrome and its components: a longitudinal study. BMC Public Health 2018 Dec 11;18(1):1366. doi: 10.1186/s12889-018-6262-3. PMID: 30537972; PMCID: PMC6288903.
  9. Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev 2010 Jul 31;62(9-10):967-78. doi:10.1016/j.addr.2010.05.005. Epub 2010 May 24. PMID: 20580916.
  10. Manodpitipong A, Saetung S, Nimitphong H et al. Night-shift work is associated with poorer glycaemic control in patients with type 2 diabetes. J Sleep Res 2017 Dec;26(6):764-772. doi: 10.1111/jsr.12554. Epub 2017 May 26. PMID: 28548389.
  11. Frank J, Gupta A, Osadchiy V et al. Brain-Gut-Microbiome Interactions and Intermittent Fasting in Obesity. Nutrients 2021 Feb 10;13(2):584. doi: 10.3390/nu13020584. PMID: 33578763; PMCID: PMC7916460.
  12. Voigt RM, Forsyth CB, Green SJ et al. Circadian disorganization alters intestinal microbiota. PLoS One 2014 May 21;9(5):e97500. doi: 10.1371/journal.pone.0097500. PMID: 24848969; PMCID: PMC4029760.
  13. Gabel K, Cienfuegos S, Kalam F et al. Time-Restricted Eating to Improve Cardiovascular Health. Curr Atheroscler Rep 2021 Mar 26;23(5):22. doi: 10.1007/s11883-021-00922-7. PMID: 33772388; PMCID: PMC8218778.
  14. Soliman GA. Intermittent fasting and time-restricted eating role in dietary interventions and precision nutrition. Front Public Health 2022 Oct 28;10:1017254. doi: 10.3389/fpubh.2022.1017254. PMID: 36388372; PMCID: PMC9650338.
  15. Mattson MP, Moehl K, Ghena N et al. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci 2018 Feb;19(2):63-80. doi: 10.1038/nrn.2017.156. Epub 2018 Jan 11. Erratum in: Nat Rev Neurosci. 2020 Aug;21(8):445. PMID: 29321682; PMCID: PMC5913738.
  16. Boyd P, O'Connor SG, Heckman-Stoddard BM et al. Time-Restricted Feeding Studies and Possible Human Benefit. JNCI Cancer Spectr 2022 May 2;6(3):pkac032. doi: 10.1093/jncics/pkac032. PMID: 35657339; PMCID: PMC9165551.
  17. Metabolic Syndrome. Accessed 24th
  18. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006;38(1):64-80. doi: 10.1080/07853890500401234. PMID: 16448990.
  19. Wilkinson MJ, Manoogian ENC, Zadourian A et al. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab 2020 Jan 7;31(1):92-104.e5. doi: 10.1016/j.cmet.2019.11.004. Epub 2019 Dec 5. PMID: 31813824; PMCID: PMC6953486.
  20. Kesztyüs D, Cermak P, Gulich M et al. Adherence to Time-Restricted Feeding and Impact on Abdominal Obesity in Primary Care Patients: Results of a Pilot Study in a Pre-Post Design. Nutrients 2019 Nov 21;11(12):2854. doi: 10.3390/nu11122854. PMID: 31766465; PMCID: PMC6950236.
  21. Simon SL, Blankenship J, Manoogian ENC et al. The impact of a self-selected time restricted eating intervention on eating patterns, sleep, and late-night eating in individuals with obesity. Front Nutr 2022 Oct 21;9:1007824. doi: 10.3389/fnut.2022.1007824. PMID: 36337640; PMCID: PMC9634110.
  22. Betts JA, Richardson JD, Chowdhury EA et al. The causal role of breakfast in energy balance and health: a randomized controlled trial in lean adults. Am J Clin Nutr 2014 Aug;100(2):539-47. doi: 10.3945/ajcn.114.083402. Epub 2014 Jun 4. PMID: 24898233; PMCID: PMC4095658.
  23. Sutton EF, Beyl R, Early KS et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab 2018 Jun 5;27(6):1212-1221.e3. doi: 10.1016/j.cmet.2018.04.010. Epub 2018 May 10. PMID: 29754952; PMCID: PMC5990470.
  24. Lowe DA, Wu N, Rohdin-Bibby L et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Intern Med 2020;180:1491–9. PubMed: 32986097.
  25. Smittenaar CR, Petersen KA, Stewart K et al. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer 2016 Oct 25;115(9):1147-1155. doi: 10.1038/bjc.2016.304. Epub 2016 Oct 11. PMID: 27727232; PMCID: PMC5117795.
  26. Zhao P, Xia N, Zhang H et al. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis. Obes Facts 2020;13(4):384-396. doi: 10.1159/000507554. Epub 2020 Jul 22. PMID: 32698183; PMCID: PMC7590763.
  27. Esposito K, Chiodini P, Colao A et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012 Nov;35(11):2402-11. doi: 10.2337/dc12-0336. PMID: 23093685; PMCID: PMC3476894.
  28. Schmitz KH, Neuhouser ML, Agurs-Collins T et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 2013 Sep 18;105(18):1344-54. doi: 10.1093/jnci/djt223. Epub 2013 Aug 29. PMID: 23990667; PMCID: PMC3776266.
  29. Christensen RAG, Kirkham AA. Time-Restricted Eating: A Novel and Simple Dietary Intervention for Primary and Secondary Prevention of Breast Cancer and Cardiovascular Disease. Nutrients 2021 Sep 30;13(10):3476. doi: 10.3390/nu13103476. PMID: 34684476; PMCID: PMC8537890.
  30. Das M, Webster NJG. Obesity, cancer risk, and time-restricted eating. Cancer Metastasis Rev 2022 Sep;41(3):697-717. doi: 10.1007/s10555-022-10061-3. Epub 2022 Aug 19. PMID: 35984550; PMCID: PMC9470651.
  31. United Nations Department of Economic and Social Affairs, Population Division, 2020. United Nations Department of Economic and Social Affairs, Population Division. World Population Ageing 2020 Highlights: Living arrangements of older persons (ST/ESA/SER.A/451)2020. Accessed 14th July 2023.
  32. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14. PMID: 30879893; PMCID: PMC6459001.
  33. Balasubramanian P, DelFavero J, Ungvari A et al. Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementia. Ageing Res Rev 2020 Dec;64:101189. doi: 10.1016/j.arr.2020.101189. Epub 2020 Sep 28. PMID: 32998063; PMCID: PMC7710623.
  34. Ezzati A, Pak VM. The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease. Exp Gerontol 2023 Jan;171:112033. doi: 10.1016/j.exger.2022.112033. Epub 2022 Nov 17. PMID: 36403899.
  35. Regmi P, Heilbronn LK. Time-Restricted Eating: Benefits, Mechanisms, and Challenges in Translation. iScience 2020 Jun 26;23(6):101161. doi: 10.1016/j.isci.2020.101161. Epub 2020 May 15. PMID: 32480126; PMCID: PMC7262456.
  36. Heymsfield SB, Gonzalez MC, Shen W et al. Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule. Obes Rev 2014 Apr;15(4):310-21. doi: 10.1111/obr.12143. Epub 2014 Jan 22. PMID: 24447775; PMCID: PMC3970209.
  37. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009 Jan;12(1):86-90. doi: 10.1097/MCO.0b013e32831cef8b. PMID: 19057193; PMCID: PMC2760315.
  38. Tinsley GM, Paoli A. Time-restricted eating and age-related muscle loss. Aging 2019 Oct 20;11(20):8741-8742. doi: 10.18632/aging.102384. Epub 2019 Oct 20. PMID: 31631066; PMCID: PMC6834432.
  39. Parr EB, Devlin BL, Hawley JA. Perspective: Time-Restricted Eating-Integrating the What with the When. Adv Nutr 2022 Jun 1;13(3):699-711. doi: 10.1093/advances/nmac015. PMID: 35170718; PMCID: PMC9156382.


  1. National Organisation for Rare Disorders (NORD) (2022). Superior Mesenteric Artery Syndrome. Available from:
  2. Genetic and Rare Diseases Information Centre (no date). Superior Mesenteric Artery Syndrome. Available from:
  3. Superior Mesenteric Artery Syndrome Research, Awareness, and Support (2021). Adult SMAS. Available from
  4. Nasser S et al (2021). Ligament of Treitz: Anatomy, Relevance of Radiologic Findings, and Radiologic-Pathologic Correlation. American Journal of Roentgenology. 216:927-934.
  5. Bhagirath Desai A et al (2015). Measurement of the Distance and Angle Between the Aorta and Superior Mesenteric Artery on CT Scan: Values in Indian Population in Different BMI Categories. The Indian journal of surgery, 77(Suppl 2), 614-617.
  6. Sophia R and Bashir WA (2012). Superior Mesenteric Artery Syndrome. New Advances in the Basic and Clinical Gastroenterology, 18:415-419. Available from:
  7. Laique SN et al (2020). Superior Mesenteric Artery Syndrome: An Unusual Cause of Abdominal Pain. Cureus, 12(11), e11505.
  8. Welsch T et al (2007). Recalling Superior Mesenteric Artery Syndrome. Digestive Surgery, 24 (3): 149-156

by Hazel Clarke, RD

  1. Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2018 Apr 1;4(4): CD000542. doi: 10.1002/14651858.CD000542.pub3. PMID: 29607496; PMCID: PMC6494406
  2. Lomer MCE, Wilson B, Wall CL. British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease. J Hum Nutr Diet. 2023 Feb; 36(1):336-377. doi: 10.1111/jhn.13054. Epub 2022 Jul 21. PMID: 35735908; PMCID: PMC10084145
  3. Bischoff SC, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE, Forbes A. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease. Clin Nutr. 2020 Mar; 39(3): 632-653. doi: 10.1016/j.clnu.2019.11.002. Epub 2020 Jan 13. PMID: 32029281
  4. Walton C, Montoya M, Fowler D et al. Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn’s disease: an observational study. Eur J Clin Nutr 70, 1052-1056 (2016).
  5. Bamba T, Shimoyama T, Sasaki M, Tsujikawa T, Fukuda Y, Koganei K, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomised, controlled trial. European Journal of Gastroenterology & Hepatology 2003;15(2):151-7
  6. Alhagamhmad MH. Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy. Nutr Clin Pract. 2018 Aug; 33(4): 483-492. doi: 10.1002/ncp.10004. Epub 2018 Jan 11. PMID: 29323428
  7. Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in Crohn's disease: Evidence and practicalities. Clin Nutr. 2019 Feb; 38(1): 80-89. doi: 10.1016/j.clnu.2018.01.020. Epub 2018 Feb 15. PMID: 29398336
  8. National Institute for Health and Care Excellence (NICE). Crohn’s Disease Management (2019).
  9. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2021;68:s1-s106
  10. Simpson K, Inniss S, Fragkos KC, Wood CPJ, Smith A, Rahman FZ. P508 Sarcopenia is associated with increased rates of infectious post-operative complications in Crohn’s disease patients. Journal of Crohn's and Colitis, Volume 17, Issue Supplement 1, February 2023, pp i639-i640
  11. University of Birmingham. OCEaN: Optimisation before Crohn's surgery using Exclusive enteral Nutrition.


  1. Lindberg S (2020, September 28). Could you be experiencing “Pregorexia?” Here’s how to break the cycle. Healthline. Retrieved September 28th, 2021
  1. Mathieu J (2009). What Is Pregorexia? Journal of the American Dietetic Association, 109(6), 976-979.
  2. National Eating Disorders Association (2018, February 22). Pregnancy and Eating Disorders.
  3. Pregorexia: A legitimate problem during pregnancy? (2020, December 11). Mayo Clinic.
  4. The Effects Of Eating Disorders In Pregnancy on Mother and Baby: A Review (2019). Psychiatria Danubina. Published.
  5. National Eating Disorders Association. (2018a, February 22). Health Consequences.
  6. Coker E and Abraham S (2015). Body weight dissatisfaction before, during and after pregnancy: a comparison of women with and without eating disorders. Eating and weight disorders: EWD, 20(1), 71-79


  1. Living Longer. Office for National Statistics (2018). Accessed January 2023, from
  2. Cost of malnutrition:
  4. Baldwin C and Weekes CE (2012). Dietary counselling with or without oral nutritional supplements in the management of malnourished patients: a systematic review and meta-analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics, 25: 411-426


  1. NICE: Overview: Food allergy in under 19s: Assessment and diagnosis: Guidance (2011) NICE. Available at: (Accessed: 25 September 2023)
  2. NHS Digital (2019). Available at: (Accessed: 25 September 2023)
  3. Lack G (2012). Update on risk factors for food allergy. Journal of Allergy and Clinical Immunology, 129(5), pp 1187-1197. doi:10.1016/j.jaci.2012.02.036
  4. Du Toit G et al (2015). Randomised trial of peanut consumption in infants at risk for peanut allergy. New England Journal of Medicine, 372(9), pp 803-813. doi:10.1056/nejmoa1414850
  5. Stiemsma L et al (2015). The Hygiene Hypothesis: Current Perspectives and Future Therapies. ImmunoTargets and Therapy, pp 143. doi:10.2147/itt.s61528
  6. van Tilburg Bernardes E and Arrieta M-C (2017). Hygiene hypothesis in asthma development: is hygiene to blame? Archives of Medical Research, 48(8), pp 717-726. doi:10.1016/j.arcmed.2017.11.009
  7. Alexandre-Silva GM et al (2018). The hygiene hypothesis at a glance: early exposures, immune mechanism and novel therapies. Acta Tropica, 188, pp 16-26. doi:10.1016/j.actatropica.2018.08.032
  8. Rook GA et al (2004). Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Seminars in Immunopathology, 25(3-4), pp 237-255. doi:10.1007/s00281-003-0148-9
  9. Hirsch AG et al (2016). Early-life antibiotic use and subsequent diagnosis of food allergy and allergic diseases. Clinical & Experimental Allergy, 47(2), pp 236-244. doi:10.1111/cea.12807
  10. Camargo CA et al (2007). Regional differences in epipen prescriptions in the United States: the potential role of Vitamin D. Journal of Allergy and Clinical Immunology, 120(1), pp 131-136. doi:10.1016/j.jaci.2007.03.049
  11. Mullins RJ, Clark S and Camargo CA (2009). Regional variation in epinephrine autoinjector prescriptions in Australia: More evidence for the vitamin D–anaphylaxis hypothesis’, Annals of Allergy, Asthma & Immunology, 103(6), pp. 488–495. doi:10.1016/s1081-1206(10)60265-7
  12. Mullins RJ et al (2011). Season of birth and childhood food allergy in Australia. Pediatric Allergy and Immunology, 22(6), pp 583-589. doi:10.1111/j.1399-3038.2011.01151.x
  13. Junge KM et al (2016). Increased vitamin D levels at birth and in early infancy increase offspring allergy risk – evidence for involvement of epigenetic mechanisms. Journal of Allergy and Clinical Immunology, 137(2), pp 610-613. doi:10.1016/j.jaci.2015.06.040
  14. Scientific Advisory Committee on Nutrition. Vitamin D and Health 2016. Available from: Accessed 25/09/2023
  15. Żukiewicz-Sobczak WA et al (2013). Causes, symptoms and prevention of food allergy, Advances in Dermatology and Allergology, 2, pp 113-116. doi:10.5114/pdia.2013.34162
  16. Chad Z (2001). Allergies in children. Paediatrics Child Health, 6(8), pp 555-566. doi:10.1093/pch/6.8.555


  1. NHS (2023) How to Start Weaning Your Baby found at: Accessed on 29th June 2023
  2. NHS (2021) Food Allergies in Babies and Young Children. Found at Accessed 29th May 2023
  3. BSACI (2018) Preventing Food Allergy In Your Baby: A Summary For Parents. Found at Accessed 29th May 2023
  4. AllergyUK (2023) Statistics and Figures. Accessed at on 29th May 2023
  5. Roberts G. et al (2022) Defining the window of opportunity and target populations to prevent peanut allergy. JACI – Food Allergy and Gastrointestinal Disease. Volume 151. Issue 3. P1329-1336
  6. Food Standards Agency  (2011) The prevalence of food allergy and weaning practices in a birth cohort of UK infants by Roberts et al. Accessed at on 29th May 2023
  7. Scarpone R, Kimkool P, Ierodiakonou D, et al. (2023) Timing of Allergenic Food Introduction and Risk of Immunoglobulin E–Mediated Food Allergy: A Systematic Review and Meta-analysis. JAMA Pediatr. 2023;177(5):489–497.
  8. Conaway, B (2022) Allergies and Eczema: What’s the Link? Accessed at,to%20get%20into%20the%20body on 29th May 2023
  9. Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol  2007;120:638-46.

by Katy Stuart RD

  1. Kovesdy C (2011). Epidemiology of chronic kidney disease: an update 2022. Kidney, Int. Suppl. 12(1): 7-11. Accessed online:
  2. Kerr M (2017). Chronic Kidney Disease in England: The Human and Financial Cost. Insight Health Economics. Accessed online:
  3. Naber T, Purohit S (2021). Chronic Kidney Disease: Role of Diet For A Reduction Of The Severity Of The Disease. Nutrients. 13(9): 3277. Accessed online:
  4. Prevention Chronic Kidney Disease (2022). Accessed online:
  5. Ko G, Rhee C, Kalanter-Zadah K, Joshi S (2021). The Effects of High Protein Diets on Kidney Health and Longevity. J Am Soc Neprhol. 31(8): 1667-1679. Accessed online:
  6. Levey A, Greene T, Beck G, Caggiula A, Kusek J, Hunsicker L, Khlar S (1999). Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (10)11: 2426-39. Accessed online:
  7. Gonzalez-Parra E, Gracia-Igquacel C, Egido J, Ortiz A (2012). Phosphorus and Nutrition in Chronic Kidney Disease. Int J Nephrol 30(5): 597-605. Accessed online:
  8. Slee A (2012). Exploring Metabolic Dysfunction in Chronic Kidney Disease. Nutr Metab 9:36 Accessed online:
  9. Inker L, Astor B, Fox C, Peralta C, Tamura M, Feldman H (2012). KDOQI US Commentary on the 2012 KDOQI Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. America Journal of Kidney Diseases. 6(5): 713-735. Accessed online:
  10. Shaman A, Kowalski S (2016). Hyperphosphetemia Management in Patients with Chronic Kidney Disease. Saudi Pharm J. 24(4): 494-505. Accessed online:,of%20secondary%20hyperparathyroidism%20(SHPT)
  11. Hruska K, Mathew S, Lund R, Qiu P, Pratt R (2008). Hyperphosphatemia of Chronic Kidney Disease. Kidney Int. 74(2):148-157. Accessed online:
  12. Elkins L (2015). Your Kidney Friendly Food Plan: Managing Phosphorus. American Kidney Fund. Accessed online:
  13. Chan S (2017). Phosphate Binders in Patients with Chronic Kidney Disease. Aust Prescr. 40(1): 10-14. Accessed online:
  14. Bianchi S. Aucella F, De Nicola L, Genovesi S, Poaletti E, Regolisti G (2019). Management of Hyperkalaemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology. J Nephrol 32(4): 499-516. Accessed online:
  15. Davita (2022). Potassium and Chronic Kidney Disease. Accessed online:,weakness%2C%20numbness%20and%20slow%20pulse.
  16. Herman L, Padala S, Ahmed I, Bashir K (2022). Angiotensin Converting Enzyme Inhibitors. Published by StatPearls. Accessed online:,%2C%20and%20hypertension.%5B1%5D
  17. Clegg D, Headley S, Germain M (2020). Impact of Dietary Potassium Restrictions in CKD on Clinical Outcomes: Benefits of a Plant-Based Diet. Kidney Med. 2(4): 476-487. Accessed online:
  18. Cases A, Cigarran-Guldris S, Mas S, Gonzalez-Parra E (2019). Vegetable-Based Diets for Chronic Kidney Disease: Is it Time to Reconsider? Nutrients. 11(6): 1263. Accessed online:
  19. Fouque D, Pelletier S, Mafra D, Chaveau P (2011). Nutrition and Chronic Kidney Disease. Kid Int 80(4): 348-357. Accessed online:
  20. National Kidney Federation (2023). Maintaining a Vegetarian Diet with Kidney Disease. Accessed online:
  21. Gluba-Brozazka A, Franczyk B, Rysk J (2017). A Vegetarian Diet in Chronic Kidney Disease: a Friend or Foe? Nutrients. 9(4): 374. Accessed online:
  22. org (2023). Vegetarian Diets for People with Kidney Disease. Accessed Online:

THE LAST WORD by Fareeha Jay, RD

  1. Diabetes UK (2019). Number of people with diabetes reaches 4.7 million. Available at:
  2. Gujral U, Pradeepa R, Weber M, Naratan K and Mohan V (2013). Type 2 diabetes in South Asians: similarities and difference with white Caucasian and other populations. Available at: doi:1111/j.1749-6632.2012.06838.x
  3. Shah A, Kanaya A (2014). Diabetes and Associated Complications in the South Asian Population. Current cardiology reports. Available at: doi:1007/s11886-014-0476-5
  4. Lucas A, Murray E and Kinra S (2013). Heath Beliefs of UK South Asians Related to Lifestyle Diseases: A Review of Qualitative Literature. Journal of Obesity. Available at:
  5. Nazar C, Bojerenu M, Safdar M and Marwat J (2016). Effectiveness of diabetes education and awareness of diabetes mellitus in combating diabetes in the United Kingdom; a literature review. Journal of nephropharmacology, pp110-115. Available at:
  6. Kumar, K., Greenfield, S., Raza, K., Gill, P. and Stach, R. (2016) ‘Understanding adherence-related beliefs about medicine amongst patients of South Asian origin with diabetes and cardiovascular disease patients: a qualitative synthesis,’ BioMed Central endocrine disorders. Available at: doi: 10.1186/s12902-016-0103-0.
  7. 8 Sohal, T., Sohal, P., King-Shier.K. and Khan, N. (2015) ‘Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review, ’PLos One. Available at: doi: 10.1371/journal.pone.0136202